Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13578
2392
mi
from 98109
Lebanon, NH
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13578
2392
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13576
2111
mi
from 98109
Amherst, NY
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13576
2111
mi
from 98109
Amherst, NY
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 38
2424
mi
from 98109
Plainview, NY
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 38
2424
mi
from 98109
Plainview, NY
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13544
2297
mi
from 98109
Greensboro, NC
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13544
2297
mi
from 98109
Greensboro, NC
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13544
2297
mi
from 98109
Greensboro, NC
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13544
2297
mi
from 98109
Greensboro, NC
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
2361
mi
from 98109
Raleigh, NC
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
2361
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1967
mi
from 98109
Cincinnati, OH
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1967
mi
from 98109
Cincinnati, OH
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 11
2020
mi
from 98109
Cleveland, OH
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 11
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1523
mi
from 98109
Oklahoma City, OK
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10183
2373
mi
from 98109
Philadelphia, PA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10183
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13560
2166
mi
from 98109
Bristol, TN
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13560
2166
mi
from 98109
Bristol, TN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 084
1864
mi
from 98109
Memphis, TN
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 084
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1310
1971
mi
from 98109
Nashville, TN
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1310
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1310
1971
mi
from 98109
Nashville, TN
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1310
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10405
mi
from 98109
Austin, TX
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10405
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1787
mi
from 98109
San Antonio, TX
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
2
mi
from 98109
Seattle, WA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13581
707
mi
from 98109
West Jordan, UT
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13581
707
mi
from 98109
West Jordan, UT
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 34
1116
mi
from 98109
Phoenix, AZ
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 34
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1779
mi
from 98109
Little Rock, AR
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1779
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13594
635
mi
from 98109
Santa Rosa, CA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13594
635
mi
from 98109
Santa Rosa, CA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10129
672
mi
from 98109
Walnut Creek, CA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10129
672
mi
from 98109
Walnut Creek, CA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10172
1067
mi
from 98109
Colorado Springs, CO
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10172
1067
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10133
1020
mi
from 98109
Denver, CO
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10133
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10171
2482
mi
from 98109
Ocala, FL
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10171
2482
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1367
1733
mi
from 98109
Chicago, IL
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1367
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 47
1868
mi
from 98109
Indianapolis, IN
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 47
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10073
1435
mi
from 98109
Wichita, KA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10073
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10113
2095
mi
from 98109
Metairie, LA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10113
2095
mi
from 98109
Metairie, LA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 024
2485
mi
from 98109
Boston, MA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 024
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site CHACHAR
2513
mi
from 98109
New Bedford, MA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site CHACHAR
2513
mi
from 98109
New Bedford, MA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
1184
mi
from 98109
Albuquerque, NM
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
1184
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1329
2041
mi
from 98109
Akron, OH
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1329
2041
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10132
250
mi
from 98109
Eugene, OR
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10132
250
mi
from 98109
Eugene, OR
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13218
2370
mi
from 98109
Jenkintown, PA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13218
2370
mi
from 98109
Jenkintown, PA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
2162
mi
from 98109
Uniontown, PA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
2162
mi
from 98109
Uniontown, PA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10487
1673
mi
from 98109
Plano, TX
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10487
1673
mi
from 98109
Plano, TX
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 66
2161
mi
from 98109
Morgantown, WV
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 66
2161
mi
from 98109
Morgantown, WV
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13632
975
mi
from 98109
Redlands, CA
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13632
975
mi
from 98109
Redlands, CA
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1297
1029
mi
from 98109
Aurora, CO
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1297
1029
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 038
1024
mi
from 98109
Englewood, CO
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 038
1024
mi
from 98109
Englewood, CO
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13071
2412
mi
from 98109
Stamford, CT
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13071
2412
mi
from 98109
Stamford, CT
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13635
2543
mi
from 98109
Bradenton, FL
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13635
2543
mi
from 98109
Bradenton, FL
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13616
2521
mi
from 98109
Pinellas Park, FL
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13616
2521
mi
from 98109
Pinellas Park, FL
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10345
mi
from 98109
Evanston, IL
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10345
mi
from 98109
Evanston, IL
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13618
1336
mi
from 98109
Fremont, NE
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13618
1336
mi
from 98109
Fremont, NE
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 60
873
mi
from 98109
Las Vegas, NV
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 60
873
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
2008
mi
from 98109
Columbus, OH
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 13615
2229
mi
from 98109
Greer, SC
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 13615
2229
mi
from 98109
Greer, SC
Click here to add this to my saved trials